Tempest Therapeutics (TPST) Amortizatization of Intangibles (2013 - 2021)
Tempest Therapeutics (TPST) posted Amortizatization of Intangibles of $143000.0 for Q1 2021, down 29.9% sequentially from $204000.0 in Q4 2020, and down 41.15% YoY from $243000.0 in Q1 2020.
Tempest Therapeutics (TPST) Amortizatization of Intangibles (2013 - 2021) Analysis & Trends
Tempest Therapeutics has reported Amortizatization of Intangibles for 9 years, with the latest figure at $143000.0 in Q1 2021.
- Quarterly Amortizatization of Intangibles fell 41.15% year-over-year to $143000.0 in Q1 2021, while the trailing twelve-month figure through Mar 2021 was $852000.0 (down 24.06% YoY) and the FY2020 annual result came in at $952000.0, changed 0.31% from the prior year.
- Amortizatization of Intangibles slipped to $143000.0 in Q1 2021 per TPST's latest filing, from $204000.0 in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $356000.0 in Q3 2019 and troughed at -$76000.0 in Q3 2018.
- A 5-year average of $120812.5 and a median of $109500.0 in 2019 frame the typical range for Amortizatization of Intangibles.
- The sharpest annual moves came in 2018 and 2019: Amortizatization of Intangibles tumbled 860.0% in 2018, then surged 568.42% in 2019.
- Over 5 years, Amortizatization of Intangibles stood at -$42000.0 in 2017, then sank by 80.95% to -$76000.0 in 2018, then surged by 410.53% to $236000.0 in 2019, then retreated by 13.56% to $204000.0 in 2020, then retreated by 29.9% to $143000.0 in 2021.
- According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $143000.0, $204000.0, and $256000.0 for Q1 2021, Q4 2020, and Q3 2020 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 678,000.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Tempest Therapeutics | 4.32 Mn | 3.52 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 143,000.00 |
| Mar 31, 2021 | 143,000.00 |
| Dec 31, 2020 | 204,000.00 |
| Dec 31, 2020 | 204,000.00 |
| Sep 30, 2020 | 256,000.00 |
| Sep 30, 2020 | 256,000.00 |
| Jun 30, 2020 | 249,000.00 |
| Jun 30, 2020 | 249,000.00 |
| Mar 31, 2020 | 243,000.00 |
| Mar 31, 2020 | 243,000.00 |
| Dec 31, 2019 | 236,000.00 |
| Dec 31, 2019 | 236,000.00 |
| Sep 30, 2019 | 356,000.00 |
| Sep 30, 2019 | 356,000.00 |
| Jun 30, 2019 | 287,000.00 |
| Jun 30, 2019 | 287,000.00 |
| Mar 31, 2019 | 76,000.00 |
| Mar 31, 2019 | 76,000.00 |
| Sep 30, 2018 | -76,000.00 |
| Sep 30, 2018 | -76,000.00 |